Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Visa
V
|
+$55.5M |
| 2 |
Strategy Inc Common Stock Class A
MSTR
|
+$35.4M |
| 3 |
International Paper
IP
|
+$25.3M |
| 4 |
DoorDash
DASH
|
+$21.9M |
| 5 |
Natera
NTRA
|
+$17.1M |
Top Sells
| 1 |
Chevron
CVX
|
+$712M |
| 2 |
Apple
AAPL
|
+$120M |
| 3 |
Interactive Brokers
IBKR
|
+$38.1M |
| 4 |
NVIDIA
NVDA
|
+$24.4M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$23.8M |
Sector Composition
| 1 | Technology | 31.47% |
| 2 | Healthcare | 11.82% |
| 3 | Consumer Discretionary | 11.72% |
| 4 | Communication Services | 9.55% |
| 5 | Industrials | 9.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1876
V2X
VVX
$1.8B
| $1.65M | ﹤0.01% |
33,600
+5,900
| +21% | +$289K |
|
1877
BioLife Solutions
BLFS
$1.23B
| $1.64M | ﹤0.01% |
71,900
| – | – |
|
1878
Sphere Entertainment
SPHR
$2.21B
| $1.64M | ﹤0.01% |
50,159
| – | – |
|
1879
Fastly
FSLY
$1.27B
| $1.64M | ﹤0.01% |
259,000
| – | – |
|
|
SVM
1880
Silvercorp Metals
SVM
$1.13B
| $1.64M | ﹤0.01% |
424,100
-4,400
| -1% | -$17K |
|
1881
Napco Security Technologies
NSSC
$1.51B
| $1.64M | ﹤0.01% |
71,100
-1,300
| -2% | -$29.9K |
|
1882
Cadre Holdings
CDRE
$1.34B
| $1.63M | ﹤0.01% |
55,100
+3,500
| +7% | +$104K |
|
1883
Worthington Steel
WS
$1.68B
| $1.63M | ﹤0.01% |
64,400
| – | – |
|
1884
Apogee Therapeutics
APGE
$2.24B
| $1.63M | ﹤0.01% |
43,600
-700
| -2% | -$26.2K |
|
1885
10x Genomics
TXG
$1.6B
| $1.63M | ﹤0.01% |
186,500
-1,900
| -1% | -$16.6K |
|
1886
Marten Transport
MRTN
$915M
| $1.62M | ﹤0.01% |
118,375
-1,800
| -1% | -$24.7K |
|
1887
Southside Bancshares
SBSI
$902M
| $1.62M | ﹤0.01% |
55,818
-800
| -1% | -$23.2K |
|
1888
Tronox
TROX
$788M
| $1.61M | ﹤0.01% |
229,400
-2,400
| -1% | -$16.9K |
|
1889
Liberty Latin America Class C
LILAK
$1.61B
| $1.61M | ﹤0.01% |
259,317
| – | – |
|
1890
Heritage Financial
HFWA
$823M
| $1.61M | ﹤0.01% |
66,168
-1,500
| -2% | -$36.5K |
|
1891
Gentherm
THRM
$1.08B
| $1.6M | ﹤0.01% |
60,000
-1,600
| -3% | -$42.8K |
|
1892
Kiniksa Pharmaceuticals
KNSA
$2.63B
| $1.6M | ﹤0.01% |
71,900
| – | – |
|
1893
Univest Financial
UVSP
$881M
| $1.6M | ﹤0.01% |
56,278
-800
| -1% | -$22.7K |
|
1894
Eos Energy Enterprises
EOSE
$2.37B
| $1.6M | ﹤0.01% |
422,200
-4,000
| -0.9% | -$15.1K |
|
1895
Revolve Group
RVLV
$1.7B
| $1.59M | ﹤0.01% |
74,200
-600
| -0.8% | -$12.9K |
|
1896
PC Connection
CNXN
$1.6B
| $1.59M | ﹤0.01% |
25,500
-300
| -1% | -$18.7K |
|
1897
Establishment Labs
ESTA
$1.13B
| $1.59M | ﹤0.01% |
39,000
+500
| +1% | +$20.4K |
|
1898
Amplitude
AMPL
$1.52B
| $1.59M | ﹤0.01% |
155,800
+4,600
| +3% | +$46.9K |
|
|
RC
1899
Ready Capital
RC
$698M
| $1.59M | ﹤0.01% |
311,656
| – | – |
|
1900
Geron
GERN
$810M
| $1.58M | ﹤0.01% |
995,500
-12,300
| -1% | -$19.6K |
|